Article
ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma.
PloS one - 1 Jan 2014
Jin Hekun, Xie Xiaoxue, Wang Hui, Hu Jun, Liu Feng, Liu Zhigang, Zhou Jumei, Zhang Yingying, Xi Xuping, Hu Bingqiang, Liao Yuping, Tang Jingtian
Abstract excerpt
BACKGROUND: Single nucleotide polymorphisms (SNPs) in DNA repair genes can alter gene expression and activity and affect response to cancer treatment and, correspondingly, survival. The present study was designed to evaluate the utility of the XRCC1 Arg399Gln and ERCC1 Cys8092Ala SNPs, measured in pretreatment biopsy samples, as predictors of response to radiotherapy in patients with non-metastatic nasopharyngeal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
